Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Pharmaceutical Companies in 2024
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2024, World Largest Pharmaceutical Companies by Market Cap in 2024.
  1. Shenzhen Kangtai Biological Products

    World Rank (Jan-05-2024)
    3,486
    Market Cap (Jan-05-2024)
    4.028 Billion USD
    World Rank (Jul-30-2023)
    3,120
    Market Cap (Jul-30-2023)
    4.727 Billion USD
    World Rank (Dec-25-2022)
    2,798
    Market Cap (Dec-25-2022)
    4.853 Billion USD
    World Rank (Jan-07-2022)
    1,935
    Market Cap (Jan-07-2022)
    9.70 Billion USD
    Annual Revenue in USD
    531 Million USD
    Annual Net Income in USD
    184 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Shenzhen Kangtai Biological Products is an integrating research, development, production and sales of biological products company.  Its products cover more than 3,130 provinces, municipalities and autonomous regions. The headquarters is in China.
  2. Livzon Pharmaceutical Group

    World Rank (Jan-05-2024)
    3,501
    Market Cap (Jan-05-2024)
    4.009 Billion USD
    World Rank (Jul-30-2023)
    3,286
    Market Cap (Jul-30-2023)
    4.448 Billion USD
    World Rank (Dec-25-2022)
    3,283
    Market Cap (Dec-25-2022)
    3.967 Billion USD
    World Rank (Jan-07-2022)
    3,126
    Market Cap (Jan-07-2022)
    5.31 Billion USD
    Annual Revenue in USD
    1,893 Million USD
    Annual Net Income in USD
    279 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Livzon Pharmaceutical Group is a comprehensive pharmaceutical group company integrating pharmaceutical R&D(Research and development), production and sales in areas of chemical drugs, traditional Chinese medicine, biological drugs and in vitro diagnostics etc. The headquarters is in China.
  3. Jointown Pharmaceutical Group

    World Rank (Jan-05-2024)
    3,508
    Market Cap (Jan-05-2024)
    3.997 Billion USD
    World Rank (Jul-30-2023)
    3,605
    Market Cap (Jul-30-2023)
    3.902 Billion USD
    World Rank (Dec-25-2022)
    3,628
    Market Cap (Dec-25-2022)
    3.530 Billion USD
    World Rank (Jan-07-2022)
    3,536
    Market Cap (Jan-07-2022)
    4.55 Billion USD
    Annual Revenue in USD
    17,813 Million USD
    Annual Net Income in USD
    356 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Jointown Pharmaceutical Group is a Chinese Pharmaceutical Preparation Manufacturing company. It provide value added information and logistics service to main target customers like pharmaceutical facilities, medical institute, whole sellers and retail pharmacies etc. The headquarters is in China.
  4. Ultragenyx Pharmaceutical

    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    363 Million USD
    Annual Operating Income in USD
    -648 Million USD
    Annual Net Income in USD
    -707 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

  5. Jiangsu Nhwa Pharmaceutical Co. Ltd

    World Rank (Jan-05-2024)
    3,576
    Market Cap (Jan-05-2024)
    3.891 Billion USD
    World Rank (Jul-30-2023)
    3,665
    Market Cap (Jul-30-2023)
    3.809 Billion USD
    World Rank (Dec-25-2022)
    3,861
    Market Cap (Dec-25-2022)
    3.261 Billion USD
    World Rank (Jan-07-2022)
    5,490
    Market Cap (Jan-07-2022)
    2.49 Billion USD
    Annual Revenue in USD
    573 Million USD
    Annual Net Income in USD
    116 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    JIANGSU NHWA PHARMACEUTICAL CO. LTD is a pharmaceutical company that fully focused on the market segments of cardiovascular drug products. The headquarters is in China.
  6. Yuhan Corporation

    World Rank (Jan-05-2024)
    3,626
    Market Cap (Jan-05-2024)
    3.827 Billion USD
    World Rank (Jul-30-2023)
    3,765
    Market Cap (Jul-30-2023)
    3.686 Billion USD
    World Rank (Dec-25-2022)
    3,979
    Market Cap (Dec-25-2022)
    3.113 Billion USD
    World Rank (Jan-07-2022)
    11,585
    Market Cap (Jan-07-2022)
    0.68 Billion USD
    Annual Revenue in USD
    1,262 Million USD
    Annual Net Income in USD
    77 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Pharmaceutical company with headquarters is in South Korea.
  7. Krka D. D.

    World Rank (Jan-05-2024)
    3,668
    Market Cap (Jan-05-2024)
    3.773 Billion USD
    World Rank (Jul-30-2023)
    3,727
    Market Cap (Jul-30-2023)
    3.730 Billion USD
    World Rank (Dec-25-2022)
    3,973
    World Rank (Jan-07-2022)
    3,973
    Annual Revenue in USD
    1,796 Million USD
    Annual Net Income in USD
    341 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    KRKA develop and market innovative generic medicines. Headquarters is in Slovenia.

  8. Glaukos Corporation

    World Rank (Jan-05-2024)
    3,675
    Market Cap (Jan-05-2024)
    3.765 Billion USD
    World Rank (Jul-30-2023)
    3,766
    Market Cap (Jul-30-2023)
    3.681 Billion USD
    World Rank (Dec-25-2022)
    5,389
    Market Cap (Dec-25-2022)
    2.034 Billion USD
    World Rank (Jan-07-2022)
    5,846
    Market Cap (Jan-07-2022)
    2.23 Billion USD
    Annual Revenue in USD
    282 Million USD
    Annual Operating Income in USD
    -102 Million USD
    Annual Net Income in USD
    -99 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Glaukos Corporation is an Ophthalmic Medical Technology and Pharmaceutical company. It platform technologies to build a comprehensive and proprietary portfolio of micro scale surgical and pharmaceutical therapies for glaucoma, corneal health and retinal diseases. The headquarters is in USA.
  9. Organon & Co.

    World Rank (Jan-05-2024)
    3,693
    Market Cap (Jan-05-2024)
    3.740 Billion USD
    World Rank (Jul-30-2023)
    2,666
    Market Cap (Jul-30-2023)
    5.649 Billion USD
    World Rank (Dec-25-2022)
    2,026
    Market Cap (Dec-25-2022)
    7.098 Billion USD
    World Rank (Jan-07-2022)
    2,198
    Market Cap (Jan-07-2022)
    8.20 Billion USD
    Annual Revenue in USD
    6,174 Million USD
    Annual Net Income in USD
    917 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Organon & Co is a Global Healthcare company with a mission to deliver impactful medicines and solutions. It is having more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. The headquarters is in USA.

  10. Haisco Pharmaceutical Group

    World Rank (Jan-05-2024)
    3,705
    Market Cap (Jan-05-2024)
    3.725 Billion USD
    World Rank (Jul-30-2023)
    3,761
    Market Cap (Jul-30-2023)
    3.688 Billion USD
    World Rank (Dec-25-2022)
    3,889
    Market Cap (Dec-25-2022)
    3.219 Billion USD
    World Rank (Jan-07-2022)
    4,526
    Market Cap (Jan-07-2022)
    3.29 Billion USD
    Annual Revenue in USD
    404 Million USD
    Annual Net Income in USD
    50 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    HAISCO PHARMACEUTICAL GROUP is a chemical pharmaceutical industries company with manufacturer of drugs for liver disease. The company specialized fields of innovative drugs and high end generic drugs involving multiple disease fields such as anaesthesia and analgesia, diabetes mellitus and complications, tumour, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory diseases. The headquarters is in China.

Share

Ads